AstraZeneca Data at ERS 2023 Demonstrate Leadership in Transforming Care Across a Broad Respiratory Portfolio of Inhaled and Biologic Medicines
August 30, 2023
August 30, 2023
WILMINGTON, Delaware, Aug. 30 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release:
AstraZeneca will present new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the European Respiratory Society (ERS) International Congress 2023, in Milan, Italy from September 9 to 13, 2023. The company will present 93 abstracts, including 18 oral presentations, which will focus on unmet needs in severe as . . .
AstraZeneca will present new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the European Respiratory Society (ERS) International Congress 2023, in Milan, Italy from September 9 to 13, 2023. The company will present 93 abstracts, including 18 oral presentations, which will focus on unmet needs in severe as . . .